23andMe Launches Rare Diseases Study

August 22, 2022
Leveraging its innovative research platform, 23andMe launched a Rare Disease Study, looking first at five rare conditions with the hopes of identifying new treatments and insights for these hard to study diseases. Researchers will start by studying systemic sclerosis, ANCA-associated vasculitis, pemphigus vulgaris, and dermatomyositis. 
Read More